Our Client is a Global Pricing and Market Access Consulting Firm that has a revolutionary platform that is changing the way payer research is being conducted around the industry.
They are going through considerable growth right now and they are looking for a number of people to join their business.
They are looking to hire from entry level to a number of senior hires.
The candidate will be home base and will be looking at Pricing and Global Market Access related projects.
• Project manager for pricing and market access project work with strong secondary research emphasis for pharmaceuticals/biotechnology products with a global remit • Taking responsibility for creating client-ready reports, presentations, and other client deliverables with senior team guidance • Managing all stages of consulting project work for strategic and operational pricing, market access due diligence, and price & revenue analytics We need a candidate with the following essential criteria: 1.
Good track record (min 3 years) in a serious PMA consultancy 2.
Strong subject area knowledge in Global or US Markets 3.
Thought leadership in PMA 4.
Proposal Writing 5.
Client Management and Development.
To apply To be considered for this position, please send your CV to ****** Keywords: Oncology, Rare Disease, Germany, Munich, EMEA, CNS, UK, Neurology, European, Europe, International, European, Market Access, MA, MAPR, MAPOR, HTA, Health Technology Assessment, Global Value Dossier, GVD, VD, London, Pricing, Pricing & Reimbursement, Market Access, HEOR, HEPRA, Health Economist, health economics, outcomes research, pricing, reimbursement, market access, Pharmaceutical, pharma, leading pharma, Head of Health Economics, Director, senior, line management, Pricing, PRO, pharmacoeconomics, Germany, UK, France, Switzerland, global, Europe, European, HTA, markov, decision tree, Health Technology, NICE, NHS, systematic literature reviews, retrospective database analyses, prospective studies, cost-effectiveness, budget impact models, HEOR, HEPRA, Health Economist, line management, health economics, outcomes research, pricing, reimbursement, market access, Pharmaceutical, pharma, leading pharma, Head of Health Economics, Director, senior, line management, Pricing, PRO, pharmacoeconomics, Germany, UK, France, Switzerland, global, Europe, European, HTA, markov, decision tree, Health Technology, NICE, NHS, systematic literature reviews, retrospective database analyses, prospective studies, cost-effectiveness, budget impact